共 18 条
[1]
Abe O, 2005, LANCET, V366, P2087, DOI 10.1016/s0140-6736(05)66544-0
[2]
PATTERNS AND RISK FACTORS OF LOCOREGIONAL RECURRENCE IN T1-T2 NODE NEGATIVE BREAST CANCER PATIENTS TREATED WITH MASTECTOMY: IMPLICATIONS FOR POSTMASTECTOMY RADIOTHERAPY
[J].
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,
2011, 81 (03)
:E151-E157
[3]
BERG JW, 1955, CANCER-AM CANCER SOC, V8, P776, DOI 10.1002/1097-0142(1955)8:4<776::AID-CNCR2820080421>3.0.CO
[4]
2-B
[9]
CHEST WALL RADIOTHERAPY: MIDDLE GROUND FOR TREATMENT OF PATIENTS WITH ONE TO THREE POSITIVE LYMPH NODES AFTER MASTECTOMY
[J].
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,
2009, 75 (05)
:1297-1303
[10]
National Institutes of Health Consensus Development Panel, 2001, J Natl Cancer Inst Monogr, P5